This Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD) is an opportunity for patients, families, and caregivers to help the FDA and other key stakeholders - including researchers, biopharma companies, healthcare providers, and federal regulatory partners - better understand what it is like to live with GSD1a and why it is imperative to explore new treatments. This meeting will be held virtually on October 9, 2025 from 10am - 3pm EST. You can simply log in and watch the meeting, or choose from various ways to participate including a pre-meeting survey, live surveys, call-in opportunities and more.
Please register below so that we can share updates and links ahead of the meeting.